AutoPhagyGO

Suita, Japan

AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.

Mar 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are AutoPhagyGO's investors?

AutoPhagyGO's investors include UHA Mikakuto, Healthcare Innovation, Moresco, Makoto Naruke.

Where is AutoPhagyGO headquartered?

AutoPhagyGO is headquartered in Suita, Japan.

What does AutoPhagyGO do?

AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.

What stage is AutoPhagyGO at?

AutoPhagyGO is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2022.

MLA

"AutoPhagyGO — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/autophagygo. Accessed July 2, 2026.

APA

VCBacked. (2022). AutoPhagyGO — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/autophagygo

Wikipedia (cite web)

{{cite web |title=AutoPhagyGO — Funding & Investors |url=https://www.vcbacked.co/company/autophagygo |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2022.